SeaStar Medical (NASDAQ:ICU) & Straumann (OTCMKTS:SAUHY) Financial Analysis

Straumann (OTCMKTS:SAUHY) and SeaStar Medical (NASDAQ:ICU) are both healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, risk, institutional ownership, earnings, valuation and profitability.

Institutional and Insider Ownership

1.7% of SeaStar Medical shares are held by institutional investors. 0.7% of SeaStar Medical shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Volatility and Risk

Straumann has a beta of 1.58, meaning that its stock price is 58% more volatile than the S&P 500. Comparatively, SeaStar Medical has a beta of -1.05, meaning that its stock price is 205% less volatile than the S&P 500.

Profitability

This table compares Straumann and SeaStar Medical’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Straumann	N/A	N/A	N/A
SeaStar Medical	-795.51%	-162.75%	-109.89%

Valuation & Earnings

This table compares Straumann and SeaStar Medical”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Straumann	$3.14 billion	6.37	$429.59 million	N/A	N/A
SeaStar Medical	$1.23 million	11.40	-$12.15 million	($4.80)	-0.66

Straumann has higher revenue and earnings than SeaStar Medical.

Analyst Ratings

This is a summary of recent recommendations for Straumann and SeaStar Medical, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Straumann	2	2	3	0	2.14
SeaStar Medical	1	0	1	0	2.00

SeaStar Medical has a consensus target price of $8.00, suggesting a potential upside of 151.57%. Given SeaStar Medical’s higher probable upside, analysts plainly believe SeaStar Medical is more favorable than Straumann.

Summary

Straumann beats SeaStar Medical on 8 of the 12 factors compared between the two stocks.

About Straumann

Straumann Holding AG provides tooth replacement and orthodontic solutions worldwide. It researches, develops, manufactures, and supplies dental implants, instruments, CADCAM prosthetics, orthodontic aligners, biomaterials, and digital solutions for use in tooth correction, replacement, and restoration, as well as to prevent tooth loss. The company offers dental implants and components made from titanium, titanium alloy, and ceramics; prosthetic elements made od ceramics, metal or polymer; and clear aligners. In addition, it offers resins for 3D printing and thermoplastics for clear aligner production; and biomaterials for tissue generation. Further, it provides digital equipment comprising scanners, milling machines and 3D printers. Further, it offers training and education services. The company provides its products to general dentists, specialists, and dental technicians and laboratories, as well as customers, such as distributors, hospitals, universities, and dental service organizations in approximately 100 countries through a network of distribution subsidiaries and partners. Straumann Holding AG was founded in 1954 and is headquartered in Basel, Switzerland.

About SeaStar Medical

SeaStar Medical Holding Corporation, a medical device company, develops a platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers inflammatory response to fend off infections and repair damaged tissue in the body. It is also developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure; myocardial stunning in end stage renal disease; and hepatorenal syndrome. The company is headquartered in Denver, Colorado.